Sangeeta Ray Banerjee
Johns Hopkins University
H-index: 41
North America-United States
Top articles of Sangeeta Ray Banerjee
Scaffolds and multifunctional intermediates for imaging PSMA and cancer therapy
2024/2/27
Preclinical Evaluation of a New Series of Albumin-Binding 177Lu-Labeled PSMA-Based Low-Molecular-Weight Radiotherapeutics
Molecules
2023/8/21
Srikanth Boinapally
H-Index: 7
Yu Yan
H-Index: 2
Rajan Singh
H-Index: 2
Il Minn
H-Index: 21
Sangeeta Ray Banerjee
H-Index: 28
Preclinical development in radiopharmaceutical therapy for prostate cancer
2023/7/18
Rajan Singh
H-Index: 2
Sangeeta Ray Banerjee
H-Index: 28
An improved 211At-labeled agent for PSMA-targeted α-therapy
Journal of Nuclear Medicine
2022/2/1
PSMA-specific degradable dextran for multiplexed immunotargeted siRNA therapeutics against prostate cancer
Nanoscale
2022
Correction to: Hetero-bivalent agents targeting FAP and PSMA
European Journal of Nuclear Medicine and Molecular Imaging
2022/11/1
Srikanth Boinapally
H-Index: 7
Il Minn
H-Index: 21
Yu Yan
H-Index: 2
Lei Zheng
H-Index: 11
Cory Brayton
H-Index: 22
Sangeeta Ray Banerjee
H-Index: 28
Prostate-specific membrane antigen (PSMA) targeted multiplexed siRNA-mediated gene silencing of CD46 and PD-L1 in prostate cancer
Cancer Research
2022/6/15
A Series of PSMA-Targeted Near-Infrared Fluorescent Imaging Agents
Biomolecules
2022/3/5
Triazole conjugated ureas, thioureas, carbamates, and reversed carbamates for PSMA-targeted imaging agents and uses thereof
2021/8/3
Preclinical evaluation of 213Bi-and 225Ac-labeled low-molecular-weight compounds for radiopharmaceutical therapy of prostate cancer
Journal of Nuclear Medicine
2021/7/1
Sangeeta Ray Banerjee
H-Index: 28
Il Minn
H-Index: 21
Vivek Kumar
H-Index: 2
Srikanth Boinapally
H-Index: 7
Cory Brayton
H-Index: 22
George Sgouros
H-Index: 38
A prostate-specific membrane antigen (PSMA)-targeted prodrug with a favorable in vivo toxicity profile
Scientific reports
2021/3/29
Dual contrast agents for fluorescence and photoacoustic imaging: evaluation in a murine model of prostate cancer
Nanoscale
2021
Yixuan Wu
H-Index: 4
Jeeun Kang
H-Index: 15
Srikanth Boinapally
H-Index: 7
Sangeeta Ray Banerjee
H-Index: 28
Prostate-specific membrane antigen (PSMA)-targeted photodynamic therapy enhances the delivery of PSMA-targeted magnetic nanoparticles to PSMA-expressing prostate tumors
Nanotheranostics
2021
Synthesis of Two Novel Mixed Bifunctional Chelating Agents: DO2AP (tBu) 4 and DO3AP (tBu) 4
Synlett
2020/8
Metal/radiometal-labeled PSMA inhibitors for PSMA-targeted imaging and radiotherapy
2022/5/5
Auger radiopharmaceutical therapy targeting prostate-specific membrane antigen in a micrometastatic model of prostate cancer
Theranostics
2020/2/3
Preclinical evaluation of 203/212Pb-labeled low-molecular-weight compounds for targeted radiopharmaceutical therapy of prostate cancer
Journal of Nuclear Medicine
2020/1/1
Sangeeta Ray Banerjee
H-Index: 28
Il Minn
H-Index: 21
Vivek Kumar
H-Index: 2
Jian Chen
H-Index: 6
Cory Brayton
H-Index: 22
George Sgouros
H-Index: 38
Co-Authors
